Skip to main content
. 2022 Apr 5;20(2):2652. doi: 10.18549/PharmPract.2022.2.2652

Table 5.

Students Satisfaction with the educational training tutorial about the clinical problem-solving process (post educational tutorial) (N = 129)

No Statements 5 4 3 2 1 Mean (SD) Median (IQR)
Part A:
1 The educational tutorial stimulated my interest in Clinical problem-solving process. 37 (28.7) 75 (58.1) 13 (10.1) 3 (2.3) 1 (0.8) 4.12 (0.74) 4 (0)
2 Methods of Clinical problem-solving process introduced in this educational tutorial are beneficial. 37 (28.7) 66 (51.2) 22 (17.1) 4 (3.1) 0 4.05 (0.76) 4 (0)
3 I enjoyed participating in this education training. 35 (27.1) 56 (43.4) 29 (22.5) 7 (5.4) 2 (1.6) 3.89 (0.92) 4 (1)
4 The educational tutorial was easy to understand. 28 (21.7) 42 (32.6) 34 (26.4) 23 (17.8) 2 (1.6) 3.55 (1.07) 4 (1)
5 The educational tutorial made me understand the concept of Clinical problem-solving process. 45 (34.9) 60 (46.5) 21 (16.3) 3 (2.3) 0 4.14 (0.77) 4 (0)
6 The educational tutorial helped me understand the importance of Clinical problem-solving process. 45 (34.9) 52 (40.3) 30 (23.3) 2 (1.6) 0 4.09 (0.80) 4 (0)
7 The educational tutorial enhanced my learning. 50 (38.8) 60 (46.5) 16 (12.4) 3 (2.3) 0 4.22 (0.75) 4 (0)
8 Wide knowledge area covered. 47 (36.4) 49 (38.0) 29 (22.5) 4 (3.1) 0 4.08 (0.84) 4 (0)
9 Wide range of clinical skills covered. 53 (41.1) 48 (37.2) 25 (19.4) 3 (2.3) 0 4.17 (0.82) 4 (0)
10 The educational tutorial well structured & sequenced. 36 (27.9) 57 (44.2) 30 (23.3) 4 (3.1) 2 (1.6) 3.94 (0.88) 4 (0)
11 Student aware of level of data and skills needed. 46 (35.7) 51 (39.5) 27 (20.9) 4 (3.1) 1 (0.8) 4.06 (0.87) 4 (0)
Part B:
1 DI resources instructions well administered. 55 (42.6) 59 (45.7) 13 (10.1) 1 (0.8) 1 (0.8) 4.29 (0.74) 4 (0)
2 DI resources skills are beneficial. 54 (41.9) 54 (41.9) 9 (7.0) 3 (2.3) 0 4.30 (0.70) 4 (1)
3 Data Collection part instructions well administrated. 41 (31.8) 56 (43.4) 28 (21.7) 4 (3.1) 0 4.04 (0.81) 4 (0)
4 Data Collection part is clear. 42 (32.6) 48 (37.2) 30 (23.3) 8 (6.2) 1 (0.8) 3.95 (0.94) 4 (1)
5 Data Collection part is beneficial. 53 (41.1) 57 (44.2) 15 (11.6) 4 (3.1) 0 4.23 (0.78) 4 (0)
6 Medication’s assessment template instructions well administrated. 43 (33.3) 54 (41.9) 25 (19.4) 5 (3.9) 2 (1.6) 4.02 (0.91) 4 (0)
7 Medication’s assessment part is clear. 42 (32.6) 51 (39.5) 24 (18.6) 10 (7.8) 2 (1.6) 3.94 (0.98) 4 (0)
8 Medication’s assessment part is beneficial. 58 (45.0) 44 (34.1) 22 (17.1) 3 (2.3) 2 (1.6) 4.19 (0.91) 4 (0)
9 The educational training helped me to be able to identify treatment-related problems (TRPs). 54 (41.9) 49 (38.0) 20 (15.5) 3 (2.3) 3 (2.3) 4.15 (0.93) 4 (0)
10 Care plan template instructions well administrated. 43 (33.3) 54 (41.9) 26 (20.2) 3 (2.3) 3 (2.3) 4.02 (0.92) 4 (0)
11 Care plan part is clear. 46 (35.7) 50 (38.8) 22 (17.1) 9 (7.0) 2 (1.6) 4.00 (0.98) 4 (0)
12 Care plan part is beneficial. 57 (44.2) 53 (41.1) 14 (10.9) 5 (3.9) 0 4.26 (0.80) 4 (0)
13 Patient education instructions well administrated. 60 (46.5) 48 (37.2) 17 (13.2) 4 (3.1) 0 4.27 (0.81) 4 (1)
14 Patient education part is clear. 58 (45.0) 48 (37.2) 20 (15.5) 3 (2.3) 0 4.25 (0.80) 4 (1)
15 Patient education part is beneficial. 53 (41.1) 58 (45.0) 15 (11.6) 3 (2.3) 0 4.25 (0.75) 4 (0)
16 It is beneficial to include the skills learned in different courses like therapeutics, OTC, training, clinical biochemistry, DI etc. 56 (43.4) 43 (33.3) 20 (15.5) 8 (6.2) 2 (1.6) 4.11 (0.99) 4 (0)
Part C:
1 Hospital case evaluation was fair. 18 (14.0) 60 (46.5) 32 (24.8) 18 (14.0) 1 (0.8) 3.59 (0.92) 4 (1)
2 Final exam was fair. 47 (36.4) 53 (41.1) 25 (19.4) 4 (3.1) 0 4.11 (0.82) 4 (0)
3 Exams well administered. 38 (29.5) 64 (49.6) 25 (19.4) 2 (1.6) 0 4.07 (0.74) 4 (0)
4 Exams very stressful. 32 (24.8) 34 (26.4) 32 (24.8) 18 (14.0) 13 (10.1) 3.42 (1.28) 4 (1)
5 Exams well structured & sequenced. 38 (29.5) 52 (40.3) 33 (25.6) 5 (3.9) 1 (0.8) 3.94 (0.88) 4 (0)
6 Personality, ethnicity, and gender do not affect scores. 63 (48.8) 36 (27.9) 23 (17.8) 5 (3.9) 2 (1.6) 4.19 (0.97) 4 (0)

5: strongly agree; 4: agree; 3: neutral; 2: disagree; 1: strongly disagree.